Display of Peptides on the Surface of Tobacco Mosaic Virus Particles

被引：0

作者：

Smith, M. L. ^{[2
]}

Fitzmaurice, W. P. ^{[3
]}

Turpen, T. H. ^{[4
]}

Palmer, K. E. ^{[1
]}

机构：

[1] Univ Louisville, Owensboro Canc Res Program, Owensboro, KY 42303 USA

[2] Large Scale Biol Corp, Vacaville, CA 95688 USA

[3] Novici Biotech, Vacaville, CA 95688 USA

[4] Technol Innovat Grp Inc, Austin, TX 78750 USA

来源：

PLANT-PRODUCED MICROBIAL VACCINES | 2009年 / 332卷

关键词：

tobacco mosaic virus; vaccine; plant; virus-like particle; papillomavirus; MALARIA VACCINE; EPITOPES; PROTEIN; IMMUNOGENICITY; INACTIVATION; PURIFICATION; PROTECTION; EXPRESSION; RESPONSES; ANTIGEN;

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In this review, we focus on the potential that tobacco mosaic virus (TMV) has as a carrier for immunogenic epitopes, and the factors that must be considered in order to bring products based on this platform to the market. Large Scale Biology Corporation developed facile and scaleable methods for manufacture of candidate peptide display vaccines based on TMV. We describe how rational design of., peptide vaccines can improve the manufacturability of particular TMV products. We also discuss downstream processing and purification of the vaccine products, with particular attention to the metrics that a product must attain in order to meet criteria for regulatory approval as injectable biologics.

引用

页码：13 / 31

页数：19

共 65 条

[1] THE EXPRESSION OF HYBRID HIV-TY VIRUS-LIKE PARTICLES IN YEAST [J].

ADAMS, SE ;

DAWSON, KM ;

GULL, K ;

KINGSMAN, SM ;

KINGSMAN, AJ .

NATURE, 1987, 329 (6134) :68-70

[2] L-Tyrosine prevents aggregation of therapeutic proteins by γ-irradiation [J].

Assemand, E ;

Lacroix, M ;

Mateescu, MA .

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2003, 38 :151-156

[3] Opinion - Therapeutic vaccination for chronic diseases: a new class of drugs in sight [J].

Bachmann, MF ;

Dyer, MR .

NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (01) :81-88A

[4] INACTIVATION OF VIRAL-ANTIGENS FOR VACCINE PREPARATION WITH PARTICULAR REFERENCE TO THE APPLICATION OF BINARY ETHYLENIMINE [J].

BAHNEMANN, HG .

VACCINE, 1990, 8 (04) :299-303

[5] Display of epitopes on the surface of tobacco mosaic virus: Impact of charge and isoelectric point of the epitope on virus-host interactions [J].

Bendahmane, M ;

Koo, M ;

Karrer, E ;

Beachy, RN .

JOURNAL OF MOLECULAR BIOLOGY, 1999, 290 (01) :9-20

[6] A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts [J].

Birkett, A ;

Lyons, K ;

Schmidt, A ;

Boyd, D ;

Oliveira, GA ;

Siddique, A ;

Nussenzweig, R ;

Calvo-Calle, JM ;

Nardin, E .

INFECTION AND IMMUNITY, 2002, 70 (12) :6860-6870

[7] A STUDY OF THE EFFECT OF CHEMICAL INACTIVANTS ON THE EPITOPES OF RIFT-VALLEY FEVER VIRUS GLYCOPROTEINS USING MONOCLONAL-ANTIBODIES [J].

BLACKBURN, NK ;

BESSELAAR, TG .

JOURNAL OF VIROLOGICAL METHODS, 1991, 33 (03) :367-374

[8] MICROBIOLOGICAL METHODS FOR QUALITY CONTROL OF MEMBRANE FILTERS [J].

BOWMAN, FW ;

CALHOUN, MP ;

WHITE, M .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (02) :222-&

[9] A universal virus inactivant for decontaminating blood and biopharmaceutical products [J].

Brown, F ;

Meyer, RF ;

Law, M ;

Kramer, E ;

Newman, JFE .

BIOLOGICALS, 1998, 26 (01) :39-47

[10] Inactivation of viruses by aziridines [J].

Brown, F .

VACCINE, 2001, 20 (3-4) :322-327

← 1 2 3 4 5 6 7 →